Trial intelligence / Profile preview

Long-acting vs Short-acting Triptorelin in PCOS IVF/ICSI

NCT02477566Unknown

Sponsor
Nanjing University
Start
Dec 2014
Primary completion
Dec 2016
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of triptorelin in polycystic ovary syndrome (PCOS) and infertility, sponsored by Nanjing University. Primary endpoint: Clinical pregnancy rate at 2 years. Status: unknown.

02

Drugs

triptorelin
03

Conditions

polycystic ovary syndrome (PCOS)infertility

Beyond the preview

Go deeper on NCT02477566.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02477566.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call